Y Suryo Rahmanto Selected Research

2- benzoylpyridine- 4,4- dimethyl- 3- thiosemicarbazone

1/2012	Bp44mT: an orally active iron chelator of the thiosemicarbazone class with potent anti-tumour efficacy.
1/2012	Iron chelators for the treatment of cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Y Suryo Rahmanto Research Topics

Disease

3	Neoplasms (Cancer) 01/2012 - 09/2007
3	Melanoma (Melanoma, Malignant) 10/2007 - 11/2006
1	Lung Neoplasms (Lung Cancer) 01/2012
1	Cardiotoxicity 01/2012
1	Weight Loss (Weight Reduction) 01/2012
1	Iron Overload 01/2012
1	Methemoglobinemia 01/2012
1	Hypoxia (Hypoxemia) 01/2012
1	Carcinogenesis 09/2007

Drug/Important Bio-Agent (IBA)

5	IronIBA 01/2012 - 11/2006
3	Transferrin (beta 2 Transferrin)IBA 10/2007 - 11/2006
3	Neoplasm Antigens (Tumor Antigens)IBA 10/2007 - 11/2006
2	di- 2- pyridylketone- 4,4- dimethyl- 3- thiosemicarbazoneIBA 01/2012 - 01/2012
2	2- benzoylpyridine- 4,4- dimethyl- 3- thiosemicarbazoneIBA 01/2012 - 01/2012
2	Chelating AgentsIBA 01/2012 - 01/2012
2	ThiosemicarbazonesIBA 01/2012 - 01/2012
1	Deferoxamine (Desferal)FDA LinkGeneric 01/2012
1	LigandsIBA 01/2012
1	Carrier Proteins (Binding Protein)IBA 10/2007
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 09/2007
1	Proteins (Proteins, Gene)FDA Link 11/2006
1	Messenger RNA (mRNA)IBA 11/2006

Therapy/Procedure

1	Oral Administration 01/2012